30.3% - 41.1%
min - max equity offered
NZ$5,500,000.00 - NZ$8,800,000.00
min - max investment sought
min investment parcel
More detailed information about this offer is contained in this Information MemorandumInformation Memorandum
Initial Public Offering of 25,000,000 Shares in The Hydroponics Company Limited (THC) at an issue price of A$0.20 per Share to raise a minimum of A$5,000,000 with attaching Options on a 1 for 2 basis.
Investments through the Equitise platform are for a minimum of A$2,000 and a maximum of A$5,000.
Oversubscriptions for up to 15,000,000 Shares with attaching Options on a 1 for 2 basis may be accepted to raise up to an additional A$3,000,000.
The Prospectus is an important document that should be read in its entirety. If you have any queries or do not understand it you should consult your professional advisers without delay.
* Fully paid Shares with one Option for nil consideration for every two Shares allotted
** 26,500,000 additional Performance Shares will be issued to Vendors. Performance Shares convert to Shares as specified milestones are achieved. The terms and conditions of the Performance Shares are detailed in Section 9.6 of the Prosepctus.
* Fully paid Shares with one option for nil consideration for every two shares allotted
N.B. These dates are indicative only and may vary. The Company, in conjunction with the Lead Manager reserves the right to vary any of the dates without prior notice subject to the Corporations Act and ASX Listing Rules.
The Hydroponics Company Limited (THC) is an Australian public company that was formed to be a leader in the development and delivery of medicinal cannabis; worldwide manufacturer and distributor of hydroponics equipment, materials and nutrients; and large-scale hydroponic greenhouse design and construction.
The burgeoning market in North America and liberalized laws surrounding cannabis production have created a high demand for the Company's hydroponic product line. The sector is experiencing strong growth as laws are passed in Australia, New Zealand, US and Canada permitting the possession and consumption of cannabis either for medicinal or recreational purposes.
The projected total economic impact of the US Cannabis Industry is estimated to be between US$24.4 and US$44 billion for 2020 representing a 250% increase over 2016 (Source: The State of Legal Marijuana Markets – 4th Edition (Mid-Year Update)).
The Company’s business is summarised in the Investor Presentation (refer to the documents section of this offer). Further and fuller details can be found in Section 2 of this Prospectus.
The Company has concluded several agreements to acquire and/or collaborate with several companies, technologies or projects that are aligned with the objectives of THC.
The investors below have committed capital to the business in this funding round.